No Data
Chordia --- rebounded significantly after three days, with research results on CDK12 inhibitors to be presented at the Japan Society of Molecular Biology.
Marked rebound after 3 days. It has been revealed that the company will present research results related to its CDK12 inhibitor at the Mini Symposium and Poster Sessions of the 47th Japan Society for Molecular Biology to be held on November 27-29. The announcement includes reports on the CDK12 inhibitor targeting RNA control stress through new "RNA trucking" in addition to the known "transcription", and how RNA trucking may impact the extent of the anti-cancer effects of CDK12 inhibitors.
Volume change rate ranking (10 o'clock) - V-Cube, DyDo, etc. are ranked.
In the ranking of volume change rates, by comparing the average volume over the last five days with the volume on the delivery day, one can understand the trends in selection and the interests of market participants. ■ Top volume change rates [As of November 27, 10:32] (Comparing the average volume over the last five days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <3681> V-Cube 3015000345 10.86324.75% 0.0263% <2590>
Chordia Therapeutics - The international nonproprietary name of the pharmaceutical CTX-712 has been established.
Chordia Therapeutics ＜ 190A ＞ announced on the 20th that the World Health Organization (WHO) has publicly released the International Nonproprietary Name (INN) for the CLK inhibitor drug CTX-712, which the company is developing, as the recommended INN (rINN). In the future, this development product will be referred to as "rogocekib" instead of the development code CTX-712. INN is the universal name for pharmaceuticals worldwide.
Chordia, etc., [stocks with attractive tastes from changes in volume].
Stock closing prices compared to the previous day and volume * <6185> SMN 352,793,344,900 * <7831> Wilco HD 135,184,398,400 * <2588> P Water 308,021,210,3300 * <3079> DVx 92,242,115,200 * <190A> Chordia 222,214,033,300 * <4288> Azugent 56,656,711,00 * <3932> Akatsuki 243,822,821,6400 * <3647> G3 HD 116,436,1400 * <
Chordia Therapeutics Advances Cancer Drug Development
Volume change rate ranking (10 o'clock) - GeoCode, KADOKAWA etc. are ranked.
※In the volume change rate ranking, you can understand the market participants' interest in trends such as speculation by comparing the average volume of the last 5 days with the volume on the delivery day. ■ Top volume change rate [As of 10:32 on November 20] (Comparison with the average volume of the last 5 days) Stock code Company name Volume 5-day average volume Volume change rate Stock price change rate <7357> Geocode 158000 3010.84 342.12% 0.06 38% <9468>
No Data
No Data